Sequence-specific correction of genomic hypoxanthine-guanine phosphoribosyl transferase mutations in lymphoblasts by small fragment homologous replacement

Oligonucleotides

Volumn 20, Issue 1, 2010, Pages 7-16

  Bedayat, Babak ^a   Abdolmohamadi, Alireza ^a,b   Ye, Lin ^c   Maurisse, Rosalie ^a   Parsi, Hooman ^a   Schwarz, Jennifer ^a   Emamekhoo, Hamid ^a,b   Nicklas, Janice A ^d   O'Neill, J Patrick ^d   Gruenert, Dieter C ^a,b,e  

^a California Pacifi C Medical Center   (United States)

^b Department of Laboratory Medicine ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Departments of Pediatrics   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GENOMIC DNA; GREEN FLUORESCENT PROTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE 1; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DNA MODIFICATION; DNA SEQUENCE; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOBLAST; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SMALL FRAGMENT HOMOLOGOUS REPLACEMENT; SOUTHERN BLOTTING; WILD TYPE;

BASE SEQUENCE; CELLS, CULTURED; CULTURE MEDIA; DNA PRIMERS; GENOMICS; GREEN FLUORESCENT PROTEINS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; MALE; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA;

ANIMALIA;

EID: 77649113650     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2009.0205     Document Type: Article

References (42)

1. ALBERTINI, R.J., NICKLAS, J.A., and O'NEILL, J.P. (1996). Future research directions for evaluating human genetic and cancer risk from environmental exposures. Environ. Health Perspect. 104, 503-510.
2. BRANDA, R.F., O'NEILL, J.P., BROOKS, E.M., TROMBLEY, L.M., and NICKLAS, J.A. (2001). The effect of folate def ciency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid cell lines that differ in p53 status. Mutat. Res. 473, 51-71.
3. BRUSCIA, E., SANGIUOLO, F., SINIBALDI, P., GONCZ, K.K., NOVELLI, G., and GRUENERT, D.C. (2002). Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther. 9, 683-685.
4. CAVAZZANA-CALVO, M., THRASHER, A., and MAVILIO, F. (2004). The future of gene therapy. Nature. 427, 779-781.
5. CHANG, J.C., and KAN, Y.W. (1981). Antenatal diagnosis of sickle cell anaemia by direct analysis of the sickle mutation. Lancet. 2, 1127-1129.
6. COLOSIMO, A., GONCZ, K.K., NOVELLI, G., DALLAPICCOLA, B., and GRUENERT, D.C. (2001). Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments. Mol. Ther. 3, 178-185.
7. COLOSIMO, A., GUIDA, V., ANTONUCCI, I., BONFINI, T., STUPPIA, L., and DALLAPICCOLA, B. (2007). Sequence-specif c modif cation of a beta-thalassemia locus by small DNA fragments in human erythroid progenitor cells. Haematologica. 92, 129-130.
8. GATZ, S.A., and WIESMULLER, L. (2006). p53 in recombination and repair. Cell Death Differ. 13, 1003-1016.
9. GONCZ, K.K., COLOSIMO, A., DALLAPICCOLA, B., GAGNE, L., HONG, K., NOVELLI, G., PAPAHADJOPOULOS, D., SAWA, T., SCHREIER, H., WIENER-KRONISH, J., XU, Z., and GRUENERT, D.C. (2001). Expression of DeltaF508 CFTR in normal mouse lung after site-specif c modif cation of CFTR sequences by SFHR. Gene Ther. 8, 961-965.
10. GONCZ, K.K., KUNZELMANN, K., XU, Z., and GRUENERT, D.C. (1998). Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments. Hum. Mol. Genet. 7, 1913-1919.
11. GONCZ, K.K., PROKOPISHYN, N.L., ABDOLMOHAMMADI, A., BEDAYAT, B., MAURISSE, R., DAVIS, B.R., and GRUENERT, D.C. (2006). Small fragment homologous replacement-mediated mod-if cation of genomic beta-globin sequences in human hematopoi-etic stem/progenitor cells. Oligonucleotides. 16, 213-224.
12. GONCZ, K.K., PROKOPISHYN, N.L., CHOW, B.L., DAVIS, B.R., and GRUENERT, D.C. (2002). Application of SFHR to gene therapy of monogenic disorders. Gene Therapy. 9, 691-694.
13. GRUENERT, D.C., BRUSCIA, E., NOVELLI, G., COLOSIMO, A., DALLAPICCOLA, B., SANGIUOLO, F., and GONCZ, K.K. (2003). Sequence-specif c modif cation of genomic DNA by small DNA fragments. J. Clin. Invest. 112, 637-641.
14. HUNGER-BERTLING, K., HARRER, P., and BERTLING, W. (1990). Short DNA fragments induce site specif c recombination in mammalian cells. Mol. Cell Biochem. 92, 107-116.
15. KAPSA, R., QUIGLEY, A., LYNCH, G.S., STEEPER, K., KORNBERG, A.J., GREGOREVIC, P., AUSTIN, L., and BYRNE, E. (2001). In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum. Gene Ther. 12, 629-642.
16. KAPSA, R.M., QUIGLEY, A.F., VADOLAS, J., STEEPER, K., IOANNOU, P.A., BYRNE, E., and KORNBERG, A.J. (2002). Targeted gene correction in the mdx mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle. Gene Therapy. 9, 695-699.
17. KENNER, O., KNEISEL, A., KLINGLER, J., BARTELT, B., SPEIT, G., VOGEL, W., and KAUFMANN, D. (2002). Targeted gene correction of hprt mutations by 45 base single-stranded oligonucle-otides. Biochem. Biophys. Res. Commun. 299, 787-792.
18. KENNER, O., LUTOMSKA, A., SPEIT, G., VOGEL, W., and KAUFMANN, D. (2004). Concurrent targeted exchange of three bases in mammalian hprt by oligonucleotides. Biochem. Biophys. Res. Commun. 321, 1017-1023.
19. KUNZELMANN, K., LEGENDRE, J.Y., KNOELL, D.L., ESCOBAR, L.C., XU, Z., and GRUENERT, D.C. (1996). Gene targeting of CFTR DNA in CF epithelial cells. Gene Therapy. 3, 859-867.
20. LIBER, H., and THILLY, W. (1982). Mutation assay at the thymidine kinase locus in diploid human lymphoblasts. Mutat. Res. 94, 467-482.
21. LU, X., LOZANO, G., and DONEHOWER, L.A. (2003). Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat. Res. 522, 69-83.
22. MAURISSE, R., FICHOU, Y., DE SEMIR, D., CHEUNG, J., FEREC, C., and GRUENERT, D.C. (2006). Gel purif cation of genomic DNA removes contaminating small DNA fragments interfering with polymerase chain reaction analysis of small fragment homologous replacement. Oligonucleotides. 16, 375-386.
23. McNAB, G.L., AHMAD, A., MISTRY, D., and STOCKLEY, R.A. (2007). Modif cation of gene expression and increase in alpha1-antitrypsin (alpha1-AT) secretion after homologous recombination in alpha1-AT-def cient monocytes. Hum Gene Ther 18, 1171-1177.
24. MEKEEL, K.L., TANG, W., KACHNIC, L.A., LUO, C.M., DEFRANK, J.S., and POWELL, S.N. (1997). Inactivation of p53 results in high rates of homologous recombination. Oncogene. 14, 1847-1857.
25. O'NEILL, J.P., JINNAH, H.A., HARRIS, J.C., and NYHAN, W.L. (2009). Lesch-Nyhan Syndrome geneReviews. (www.ncbi.nlm. nih.gov/bookshelf/br.fcgi?book= gene&part=lns).
26. NYHAN, W., and WONG, D. (1996). New approaches to understanding Lesch-Nyhan disease. N. Engl. J. Med. 334, 1602-1604.
27. RICHARDSON, P.D., KREN, B.T., and STEER, C.J. (2002). Gene repair in the new age of gene therapy. Hepatology. 35, 512-518.
28. SAINTIGNY, Y., BERTRAND, P., and LOPEZ, B.S. (2005). [Direct role of p53 on homologous recombination]. Med. Sci. (Paris) 21, 43-48.
29. SANGIUOLO, F., BRUSCIA, E., SERAFINO, A., NARDONE, A.M., BONIFAZI, E., LAIS, M., GRUENERT, D.C., and NOVELLI, G. (2002). In vitro correction of cystic f brosis epithelial cell lines by small fragment homologous replacement (SFHR) technique. BMC Med. Genet. 3, 8.
30. SANGIUOLO, F., FILARETO, A., SPITALIERI, P., SCALDAFERRI, M.L., MANGO, R., BRUSCIA, E., CITRO, G., BRUNETTI, E., DE FELICI, M., and NOVELLI, G. (2005). In vitro restoration of functional SMN protein in human trophoblast cells affected by spinal muscular atrophy by small fragment homologous replacement. Hum. Gene Ther. 16, 869-880.
31. SANGIUOLO, F., SCALDAFERRI, M.L., FILARETO, A., SPITALIERI, P., GUERRA, L., FAVIA, M., CAROPPO, R., MANGO, R., BRUSCIA, E., and GRUENERT, D.C. (2008). Cftr gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR). Front Biosci. 13, 2989-2999.
32. THORPE, P., STEVENSON, B., GOHIL, A., and PORTEOUS, D.J. (2000). Towards CFTR gene correction: a comparison of two key strategies. Pediatr. Pulmonal. Suppl. 20, 241.
33. THORPE, P., STEVENSON, B.J., and PORTEOUS, D.J. (2002). Optimising gene repair strategies in cell culture. Gene Ther. 9, 700-702.
34. TODARO, M., QUIGLEY, A., KITA, M., CHIN, J., LOWES, K., KORNBERG, A.J., COOK, M.J., and KAPSA, R. (2007). Effective detection of corrected dystrophin loci in mdx mouse myogenic precursors. Hum. Mutat. 28, 816-823.
35. TSUCHIYA, H., HARASHIMA, H., and KAMIYA, H. (2005a). Factors affecting SFHR gene correction eff ciency with single-stranded DNA fragment. Biochem. Biophys. Res. Commun. 336, 1194-1200.
36. TSUCHIYA, H., HARASHIMA, H., and KAMIYA, H. (2005b). Increased SFHR gene correction eff ciency with sense single-stranded DNA. J. Gene Med. 7, 486-493. (Pubitemid 40553129)
37. TSUCHIYA, H., SAWAMURA, T., HARASHIMA, H., and KAMIYA, H. (2005c). Correction of frameshift mutations with single-stranded and double-stranded DNA fragments prepared from phagemid/plasmid DNAs. Biol. Pharm. Bull. 28, 1958-1962.
38. YANEZ, R.J., and PORTER, A.C. (1999). Gene targeting is enhanced in human cells overexpressing hRAD51. Gene Ther. 6, 1282-1290.
39. YANEZ, R.J., and PORTER, A.C. (2002). Differential effects of Rad52p overexpression on gene targeting and extrachromosomal homologous recombination in a human cell line. Nucleic Acids Res. 30, 740-74 8.
40. YANEZ, R.J., and PORTER, A.C.G. (1998). Therapeutic gene targeting. Gene Ther. 5, 149-159.
41. YOON, D., WANG, Y., STAPLEFORD, K., WIESMULLER, L., and CHEN, J. (2004). P53 inhibits strand exchange and replication fork regression promoted by human Rad51. J. Mol. Biol. 336, 639-654.
42. ZAYED, H., MCIVOR, R.S., WIEST, D.L., and BLAZAR, B.R. (2006). In vitro functional correction of the mutation responsible for murine severe combined immune def ciency by small fragment homologous replacement. Hum. Gene Ther. 17, 158-166.